Politico, November 7, 2019. While EPA wants to shut down facilities that sterilize medical devices using a carcinogenic chemical, the EPA and FDA should have harmonized their standards years ago to protect patients and consumers.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
As Essure Implant Return Deadline Nears, FDA Study Enrollment Inches Up
MedTech Dive, November 5, 2019. The original clinical data supporting FDA’s approval of Essure was insufficient, as seen in Bayer’s small sample size in the Essure postmarket study.
Read More »FDA Keeps Brand-Name Drugs on a Fast Path to Market ― Despite Manufacturing Concerns
Kaiser Health News and Daily Beast, November 3, 2019. More caution is warranted as the FDA keeps brand-name drugs on the fast path to the market, despite concerns about manufacturing and pre-market inspections.
Read More »When Recalls Fail: Many harmful products remain in homes and stores. Why that happens, what needs to change, and how to protect yourself.
Consumer Reports, October 31, 2019. Whether it be contaminated food, deadly infant sleepers, breast implants, or other unsafe products, recalls are not protecting us as well as they should be.
Read More »FDA calls for new warnings for breast implants
The Washington Post, October 23, 2019. Due to problems with breast implants, FDA calls for new warnings associated with the implants as well as providing more information about the devices.
Read More »